The group’s principle activity is to develop new technology and pioneering products to provide symptomatic relief for, and may help to slow the progression of chronic kidney failure. The group’s products include Kibow biotics(R) and metabolic syndrome products. The group operates from United States.
Executive Information
Name
Title
Email
Natarajan Ranganathan
Principal Founder, CEO, Sr. VP - Research & Development
